Briggs Morrison's Net Worth
$18.8 Million
Who is Briggs Morrison?
Briggs Morrison has an estimated net worth of $18.8 Million. This is based on reported shares across multiple companies, which include Repare Therapeutics Inc., Syndax Pharmaceuticals Inc, ARVINAS, INC., Codiak BioSciences, Inc., NextCure, Inc., Werewolf Therapeutics, Inc., Oncorus, Inc., and Carisma Therapeutics Inc..
SEC CIK
Briggs Morrison's CIK is 0001654430
Past Insider Trading and Trends
2022 was Briggs Morrison's most active year for acquiring shares with 17 total transactions. Briggs Morrison's most active month to acquire stocks was the month of May. 2022 was Briggs Morrison's most active year for disposing of shares, totalling 31 transactions. Briggs Morrison's most active month to dispose stocks was the month of August. 2022 saw Briggs Morrison paying a total of $8,930,918.70 for 926,214 shares, this is the most they've acquired in one year. In 2022 Briggs Morrison cashed out on 1,357,215 shares for a total of $16,395,184.89, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
∞
| 4.8K |
$20.00 | $96,000.00 | 4.8K |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
President, Head R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.31% | 17K |
—
|
—
| 34.84K |
Feb 7
| |||
Form 4
|
—
|
0
|
$13.52 | -$501,863.51 | 17.84K |
Aug 9
| |||
Form 4
|
—
|
0
|
$14.59 | -$614,529.23 | 17.84K |
Jul 10
| |||
Form 4
|
—
|
0
|
$14.42 | -$714,633.96 | 17.84K |
Jun 9
| |||
Form 4
|
—
|
0
|
$13.90 | -$794,262.66 | 17.84K |
May 9
| |||
Form 4
|
—
|
0
|
$12.96 | -$695,022.11 | 17.84K |
Apr 10
| |||
Form 4
|
—
|
0
|
$14.46 | -$853,465.25 | 17.84K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
$16.61 | -$1,080,700.45 | 17.84K |
Scheduled
|
Feb 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
$17.01 | -$2,123,587.26 | 17.84K |
Scheduled
|
Sep 19 - Sep 20
| ||
Form 4
|
—
|
0
|
$15.77 | -$4,396,277.42 | 17.84K |
Scheduled
|
Sep 14 - Sep 16
| ||
Form 4
|
—
|
0
|
$13.10 | -$734,927.25 | 17.84K |
Scheduled
|
Jul 1
| ||
Form 4/A
| +206.53% | 73.67K |
$7.20 | $530,445.60 | 109.34K |
Apr 1 - Apr 4
| |||
Form 4
| -63.10% | -30.50K |
$14.19 | -$1,017,699.43 | 17.84K |
Scheduled
|
Apr 1 - Apr 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
$15.45 | -$319,919.60 | 48.34K |
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
$13.64 | -$904,771.42 | 48.34K |
Scheduled
|
Sep 17 - Sep 20
| ||
Form 4
|
—
|
0
|
$13.88 | -$469,279.87 | 48.34K |
Scheduled
|
Feb 8
| ||
Form 4
| +3.80% | 1.77K |
$12.00 | $21,252.00 | 48.34K |
Jan 31 - Feb 3
| |||
Form 4
|
—
|
0
|
$13.62 | -$1,032,668.20 | 46.56K |
Nov 9 - Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +39.81% | 12.5K |
$8.00 | $100,000.00 | 43.9K |
Feb 4
| |||
Form 4
| +53.92% | 11K |
$5.40 | $59,400.00 | 31.4K |
Oct 10
| |||
Form 4
|
∞
| 20.4K |
$7.46 | $152,242.80 | 20.4K |
May 9 - May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARVINAS, INC. (ARVN) Snapshot price: $24.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.48% | 5.9K |
—
|
—
| 30K |
May 29
| |||
Form 4
| +20.63% | 4.12K |
—
|
—
| 24.1K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -19.28% | -4.77K |
$41.22 | -$1,133,607.84 | 19.98K |
Scheduled
|
Apr 14
| ||
Form 4
| -16.17% | -4.77K |
$40.78 | -$1,115,012.57 | 24.75K |
Scheduled
|
Jan 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +9.25% | 2.5K |
$38.18 | $95,450.00 | 29.52K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Codiak BioSciences, Inc. (CDAKQ) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.76K |
$21.00 | $99,981.00 | 4.76K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NextCure, Inc. (NXTC) Snapshot price: $1.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||